A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON) von Mathieu, C., Rodbard, H. W., Cariou, B., Handelsman, Y., Philis-Tsimikas, A., Ocampo Francisco, A. M., Rana, A., Zinman, B.

Volltext

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial von Rodbard, H. W., Cariou, B., Zinman, B., Handelsman, Y., Philis-Tsimikas, A., Skjøth, T. V., Rana, A., Mathieu, C.

Volltext

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (... von Aroda, V. R., Bailey, T. S., Cariou, B., Kumar, S., Leiter, L. A., Raskin, P., Zacho, J., Andersen, T. H., Philis-Tsimikas, A.

Volltext

Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents von Philis-Tsimikas, A., Del Prato, S., Satman, I., Bhargava, A., Dharmalingam, M., Skjøth, T. V., Rasmussen, S., Garber, A. J.

Volltext

Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-t... von Philis-Tsimikas, A., Astamirova, K., Gupta, Y., Haggag, A., Roula, D., Bak, B.A., Fita, E.G., Nielsen, A.M., Demir, T.

Volltext

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial von Del Prato, Stefano, Pavo, Imre, Weerakkody, Govinda J, Yang, Zhengyu, Aizenberg, Diego, Wynne, Alan G, Wiese, Russell J, Arora, Samir, Calderon, Rafael B, Butuk, David J, Chaychi, Leila, Curtis, Brian M, Chochinov, Ronald, Chow, Christopher, Cone, Clancy L, Dungan, Kathleen, Gaudiani, Linda, Herandez-Vazquez, Luis, Hsia, Stanley H, Kutner, Mark E, Loy, Juan, Miranda, Francisco G, Oliver, Michael J, Parke, Michael T, Philis-Tsimikas, Athena, Rosenstock, Julio, Sorial, Ehab, Stonesifer, Larry D, Stringam, Stanley, Van, Joanna T, Vazquez-Tanus, Jose B, Reyes, Ramon, Karimjee, Najmuddin, Martin, Earl E, Fraser, Neil J, Bhargava, Anuj, Wynne, Alan G, Billings, Liana, Walsh, Patrick, Shubrook, Jay, Knouse, Albert B, Mayfield, Ronald K, Bitar, Fahed G, de la Cuesta, Carmen, Morales Portillo, Cristobal J, Quesada Charneco, Miguel, Tofe Povedano, Santiago, Vazquez, Luis, Soto Gonzalez, Alfonso, Ciomos, Daniela, Neacsu, Valentina, Stern, Naftali, Sofer, Yael, Sack, Jessica, Tirosh, Amir, Shehadeh, Naim, Darawsha, Mahmud, Skripova, Dasa, Pavleova, Eva, Kubincova, Ludmila, Merciakova, Martina, St-Amour, Eric, Yared, Zeina, Blouin, Francois, Aggarwal, Naresh K, Bajaj, Harpreet, Tailor, Chetna, Egan, Alan, St.Onge, Natasha, Borges, Joao L C, Franco, Denise R, Souza, Filipe D, Russo, Luis Augusto T, Sassone, Sonia A, Steinacher, Andrea, Perez Manghi, Federico C, Orio, Silvia I, Gelersztein, Elizabeth, Fretes, José O, Calella, Pedro R F, Zaidman, Cesar J, Chertkoff, Alejandro, Gonzalez Galvez, Guillermo, Calvo, Cesar G, Sowinski, Dariusz, Jozefowska, Malgorzata, Skokowska, Ewa, Modzelewska, Anna, Gilfillan, Christopher, Morbey, Claire, Kaur, Kamal, Kemp, Laurence, Shea, Antony J, Kunitsyna, Marina A, Ou, Horng-Yih, Chen, Jung-Fu, Hwu, Chii-Min, Doupis, John, Pagkalos, Emmanouil, Mouslech, Zadalla

Volltext

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes von Marso, Steven P, McGuire, Darren K, Zinman, Bernard, Poulter, Neil R, Emerson, Scott S, Pieber, Thomas R, Pratley, Richard E, Haahr, Poul-Martin, Lange, Martin, Brown-Frandsen, Kirstine, Moses, Alan, Skibsted, Simon, Kvist, Kajsa, Buse, John B

Volltext

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment von Rosenstock, Julio, Bajaj, Harpreet S, Janež, Andrej, Silver, Robert, Begtrup, Kamilla, Hansen, Melissa V, Jia, Ting, Goldenberg, Ronald

Volltext

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study von Drucker, Daniel J, Dr, Buse, John B, MD, Taylor, Kristin, PhD, Kendall, David M, MD, Trautmann, Michael, MD, Zhuang, Dongliang, PhD, Porter, Lisa, MD

Volltext

PO424 THE EFFECT OF INSULIN DEGLUDEC IN COMBINATION WITH LIRAGLUTIDE AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES REQUIRING TREATMENT INTENSIFICATION von Aroda, V, Bailey, T, Cariou, B, Kumar, S, Leiter, L, Raskin, P, Zacho, J, Bandier, M, Philis-Tsimikas, A

Volltext

P21 Effect of insulin degludec vs insulin glargine in a one-year randomized trial in insulin-naïve patients with type 2 diabetes von Rana, A, Zinman, B, Philis-Tsimikas, A, Handelsman, Y, Rodbard, H.W, Cariou, B, Endahl, L, Mathieu, C

Volltext

Insulin degludec is superior to sitagliptin in improving glycaemic control in insulin-naïve patients with type 2 diabetes von Kapur, R, Philis-Tsimikas, A, Del Prato, S, Satman, I, Bhargava, A, Dharmalingham, M, Skjøth, T.V, Garber, A.J

Volltext

IDF21-0140 Higher derived time in range with insulin degludec/insulin aspart vs insulin glargine U100 in Japanese adults with T2D von Philis-Tsimikas, A., D'Cruz, J.M., De Block, C., Hachmann-Nielsen, E., Sivarathinasami, R., Onishi, Y.

Volltext

Évaluation du contrôle glycémique par la mesure continue du glucose chez les patients diabétiques de type 2 traités par IDegLira von Cariou, B, Vilsbøll, T, Philis-Tsimikas, A, Langbakke, I, Begtrup, K, King, A, Bouzidi, A

Volltext

P310 L’hypoglycémie liée à l’activité physique apparaît à une fréquence similaire avec l’insuline dégludec et l’insuline glargine von Gouet, D, Heller, S, Gough, S, Oyer, D, Jensen, K, Kinduryte, O, Philis-Tsimikas, A

Volltext

Improved care for diabetes in underserved populations von Philis-Tsimikas, A, Walker, C

Volltext

L’insuline asparte ultra-rapide vs insuline asparte en prandiale améliore le contrôle glycémique chez les patients DT1 : étude onset® 1 von Benhamou, P.Y, Russell-Jones, D, Bode, B.W, Franek, E, Heller, S, Chantal, M, Philis-Tsimikas, A, Rose, L, Woo, V, Birk østerskov, A, Graungaard, T, Bergenstal, R, Kessouri, M

Volltext

PDB124 REAL WORLD CHART REVIEW EXAMINATION OF LORCASERIN TREATMENT IN WEIGHT MANAGEMENT von Harris, S.R., Knoth, R.L., Khilfeh, I., Li, X., Choi, J., Philis-Tsimikas, A., Fujioka, K.

Volltext

P1096 L’insuline dégludec est supérieure à la sitagliptine pour l’amélioration du contrôle glycémique chez les sujets diabétiques de Type 2 (DT2) : résultats d’un essai randomisé d... von Raccah, D, Philis-Tsimikas, A, Del Prato, S, Satman, I, Bhargava, A, Dharmalingam, M, Vang Skjøth, T, Rasmussen, S, Garber, A.J

Volltext

Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study von Benoit, Stephen R, Fleming, Regina, Philis-Tsimikas, Athena, Ji, Ming

Volltext